Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Dobutamine Dobutamine 💬Adrenergic signaling in cardiomyocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Dobutamine tartrate Dobutamine tartrate 💬Adrenergic signaling in cardiomyocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬4. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬Adrenergic signaling in cardiomyocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬4. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬6. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬6. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬8. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬8. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism
|
Ketamine hydrochloride Ketamine hydrochloride 💬Alcoholism
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬10. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism
|
Ketamine Ketamine 💬Alcoholism
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬10. Alcoholism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬12. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬12. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
NR3C2 1件: NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Eplerenone Eplerenone 💬Aldosterone-regulated sodium reabsorption
| Eplerenone | 057 5件: 57, 75, 113, 210, 215 💬14. Aldosterone-regulated sodium reabsorption
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease
|
Ketamine hydrochloride Ketamine hydrochloride 💬Alzheimer disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬15. Alzheimer disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease
|
Ketamine Ketamine 💬Alzheimer disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬15. Alzheimer disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction
|
Ketamine hydrochloride Ketamine hydrochloride 💬Amphetamine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬17. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction
|
Ketamine Ketamine 💬Amphetamine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬17. Amphetamine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis
|
Ketamine hydrochloride Ketamine hydrochloride 💬Amyotrophic lateral sclerosis
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬19. Amyotrophic lateral sclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis
|
Ketamine Ketamine 💬Amyotrophic lateral sclerosis
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬19. Amyotrophic lateral sclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬21. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬21. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Calcium signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬23. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Dobutamine Dobutamine 💬Calcium signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬23. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Dobutamine tartrate Dobutamine tartrate 💬Calcium signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬23. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Calcium signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬26. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Calcium signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬26. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬28. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬28. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway
|
Ketamine hydrochloride Ketamine hydrochloride 💬Calcium signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬30. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway
|
Ketamine Ketamine 💬Calcium signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬30. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬cAMP signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬32. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Dobutamine Dobutamine 💬cAMP signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬32. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Dobutamine tartrate Dobutamine tartrate 💬cAMP signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬32. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬cAMP signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬35. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬cAMP signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬35. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway
|
Ketamine hydrochloride Ketamine hydrochloride 💬cAMP signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬37. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway
|
Ketamine Ketamine 💬cAMP signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬37. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬39. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬39. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬cGMP-PKG signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬41. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Dobutamine Dobutamine 💬cGMP-PKG signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬41. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Dobutamine tartrate Dobutamine tartrate 💬cGMP-PKG signaling pathway
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬41. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬cGMP-PKG signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬44. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬cGMP-PKG signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬44. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬46. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬46. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Chemical carcinogenesis - receptor activation
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬48. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Dobutamine Dobutamine 💬Chemical carcinogenesis - receptor activation
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬48. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Dobutamine tartrate Dobutamine tartrate 💬Chemical carcinogenesis - receptor activation
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬48. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Chemical carcinogenesis - receptor activation
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬51. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Chemical carcinogenesis - receptor activation
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬51. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment
|
Ketamine hydrochloride Ketamine hydrochloride 💬Circadian entrainment
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬53. Circadian entrainment
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment
|
Ketamine Ketamine 💬Circadian entrainment
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬53. Circadian entrainment
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Cocaine addiction 💬 15 genes, 67 drugs (DrugBank) and 58 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction
|
Ketamine hydrochloride Ketamine hydrochloride 💬Cocaine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬55. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Cocaine addiction 💬 15 genes, 67 drugs (DrugBank) and 58 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction
|
Ketamine Ketamine 💬Cocaine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬55. Cocaine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
PLG 1件: PLG 💬Complement and coagulation cascades
|
Tranexamic acid Tranexamic acid 💬Complement and coagulation cascades
| Tranexamic acid | 046 7件: 46, 65, 70, 215, 227, 274, 299 💬57. Complement and coagulation cascades
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Losartan potassium Losartan potassium 💬Coronavirus disease
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬58. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Losartan Losartan 💬Coronavirus disease
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬58. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬60. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬60. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬62. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬62. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬64. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬64. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Dilated cardiomyopathy
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬66. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Dobutamine Dobutamine 💬Dilated cardiomyopathy
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬66. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Dobutamine tartrate Dobutamine tartrate 💬Dilated cardiomyopathy
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬66. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Propranolol hydrochloride Propranolol hydrochloride 💬Dilated cardiomyopathy
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬69. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Propranolol Propranolol 💬Dilated cardiomyopathy
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬69. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
GRIN2A 2件: GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Dopaminergic synapse
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬71. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
GRIN2A 2件: GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Dopaminergic synapse
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬71. Dopaminergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Drug metabolism - other enzymes 💬 9 genes, 13 drugs (DrugBank) and 58 diseases |
TK2 1件: TK2 💬Drug metabolism - other enzymes
|
Doxribtimine Doxribtimine 💬Drug metabolism - other enzymes
| Thymidine | 215 2件: 215, 216 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
OPRM1 1件: OPRM1 💬Estrogen signaling pathway
|
Fentanyl Fentanyl 💬Estrogen signaling pathway
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
OPRM1 1件: OPRM1 💬Estrogen signaling pathway
|
Fentanyl citrate Fentanyl citrate 💬Estrogen signaling pathway
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
OPRM1 1件: OPRM1 💬Estrogen signaling pathway
|
Fentanyl hydrochloride Fentanyl hydrochloride 💬Estrogen signaling pathway
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Gap junction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬77. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Dobutamine Dobutamine 💬Gap junction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬77. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Dobutamine tartrate Dobutamine tartrate 💬Gap junction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬77. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Propranolol hydrochloride Propranolol hydrochloride 💬Gap junction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬80. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Propranolol Propranolol 💬Gap junction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬80. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Glutamatergic synapse 💬 23 genes, 32 drugs (DrugBank) and 82 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse
|
Ketamine hydrochloride Ketamine hydrochloride 💬Glutamatergic synapse
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬82. Glutamatergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Glutamatergic synapse 💬 23 genes, 32 drugs (DrugBank) and 82 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse
|
Ketamine Ketamine 💬Glutamatergic synapse
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬82. Glutamatergic synapse
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Hormone signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬84. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Hormone signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬84. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Hormone signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬86. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Dobutamine Dobutamine 💬Hormone signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬86. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Dobutamine tartrate Dobutamine tartrate 💬Hormone signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬86. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Hormone signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬89. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Hormone signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬89. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬91. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬91. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
OPRM1 1件: OPRM1 💬Hormone signaling
|
Fentanyl Fentanyl 💬Hormone signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
OPRM1 1件: OPRM1 💬Hormone signaling
|
Fentanyl citrate Fentanyl citrate 💬Hormone signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
OPRM1 1件: OPRM1 💬Hormone signaling
|
Fentanyl hydrochloride Fentanyl hydrochloride 💬Hormone signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
GRIN1 2件: GRIN1, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Huntington disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬96. Huntington disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
GRIN1 2件: GRIN1, GRIN2B 💬
|
Ketamine Ketamine 💬Huntington disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬96. Huntington disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
PLG 1件: PLG 💬Influenza A
|
Tranexamic acid Tranexamic acid 💬Influenza A
| Tranexamic acid | 046 7件: 46, 65, 70, 215, 227, 274, 299 💬98. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Long-term potentiation 💬 18 genes, 37 drugs (DrugBank) and 87 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation
|
Ketamine hydrochloride Ketamine hydrochloride 💬Long-term potentiation
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬99. Long-term potentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Long-term potentiation 💬 18 genes, 37 drugs (DrugBank) and 87 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation
|
Ketamine Ketamine 💬Long-term potentiation
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬99. Long-term potentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
OPRM1 1件: OPRM1 💬Morphine addiction
|
Fentanyl Fentanyl 💬Morphine addiction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
OPRM1 1件: OPRM1 💬Morphine addiction
|
Fentanyl citrate Fentanyl citrate 💬Morphine addiction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
OPRM1 1件: OPRM1 💬Morphine addiction
|
Fentanyl hydrochloride Fentanyl hydrochloride 💬Morphine addiction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬104. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬104. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Neuroactive ligand signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬106. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Dobutamine Dobutamine 💬Neuroactive ligand signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬106. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Dobutamine tartrate Dobutamine tartrate 💬Neuroactive ligand signaling
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬106. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Neuroactive ligand signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬109. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬Neuroactive ligand signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬109. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling
|
Ketamine hydrochloride Ketamine hydrochloride 💬Neuroactive ligand signaling
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬111. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling
|
Ketamine Ketamine 💬Neuroactive ligand signaling
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬111. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand signaling
|
Fentanyl Fentanyl 💬Neuroactive ligand signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand signaling
|
Fentanyl citrate Fentanyl citrate 💬Neuroactive ligand signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand signaling
|
Fentanyl hydrochloride Fentanyl hydrochloride 💬Neuroactive ligand signaling
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬116. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 15件: 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬116. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬118. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Dobutamine Dobutamine 💬Neuroactive ligand-receptor interaction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬118. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Dobutamine tartrate Dobutamine tartrate 💬Neuroactive ligand-receptor interaction
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬118. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Neuroactive ligand-receptor interaction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬121. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Neuroactive ligand-receptor interaction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬121. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬123. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬123. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction
|
Ketamine hydrochloride Ketamine hydrochloride 💬Neuroactive ligand-receptor interaction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬125. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction
|
Ketamine Ketamine 💬Neuroactive ligand-receptor interaction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬125. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand-receptor interaction
|
Fentanyl Fentanyl 💬Neuroactive ligand-receptor interaction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand-receptor interaction
|
Fentanyl citrate Fentanyl citrate 💬Neuroactive ligand-receptor interaction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
OPRM1 1件: OPRM1 💬Neuroactive ligand-receptor interaction
|
Fentanyl hydrochloride Fentanyl hydrochloride 💬Neuroactive ligand-receptor interaction
| Fentanyl | 046 6件: 46, 70, 97, 215, 231, 298 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PLG 1件: PLG 💬Neuroactive ligand-receptor interaction
|
Tranexamic acid Tranexamic acid 💬Neuroactive ligand-receptor interaction
| Tranexamic acid | 046 7件: 46, 65, 70, 215, 227, 274, 299 💬130. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Nicotine addiction 💬 30 genes, 37 drugs (DrugBank) and 48 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction
|
Ketamine hydrochloride Ketamine hydrochloride 💬Nicotine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬131. Nicotine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Nicotine addiction 💬 30 genes, 37 drugs (DrugBank) and 48 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction
|
Ketamine Ketamine 💬Nicotine addiction
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬131. Nicotine addiction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬133. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬133. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases
|
Ketamine hydrochloride Ketamine hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬135. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases
|
Ketamine Ketamine 💬Pathways of neurodegeneration - multiple diseases
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬135. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬137. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬137. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease
|
Ketamine hydrochloride Ketamine hydrochloride 💬Prion disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬139. Prion disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease
|
Ketamine Ketamine 💬Prion disease
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬139. Prion disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Pyrimidine metabolism 💬 5 genes, 9 drugs (DrugBank) and 49 diseases |
TK2 1件: TK2 💬Pyrimidine metabolism
|
Doxribtimine Doxribtimine 💬Pyrimidine metabolism
| Thymidine | 215 2件: 215, 216 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
GRIN1 3件: GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Rap1 signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬142. Rap1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
GRIN1 3件: GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Rap1 signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬142. Rap1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
GRIN1 3件: GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Ras signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬144. Ras signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
GRIN1 3件: GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Ras signaling pathway
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬144. Ras signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Regulation of lipolysis in adipocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬146. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Dobutamine Dobutamine 💬Regulation of lipolysis in adipocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬146. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Dobutamine tartrate Dobutamine tartrate 💬Regulation of lipolysis in adipocytes
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬146. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Regulation of lipolysis in adipocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬149. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Regulation of lipolysis in adipocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬149. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Renin secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬151. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Dobutamine Dobutamine 💬Renin secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬151. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Dobutamine tartrate Dobutamine tartrate 💬Renin secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬151. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Renin secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬154. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Renin secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬154. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬156. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬156. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬158. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬158. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Dobutamine hydrochloride Dobutamine hydrochloride 💬Salivary secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬160. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Dobutamine Dobutamine 💬Salivary secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬160. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Dobutamine tartrate Dobutamine tartrate 💬Salivary secretion
| Dobutamine | 028 5件: 28, 57, 58, 86, 215 💬160. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Salivary secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬163. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Salivary secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬163. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Spinocerebellar ataxia 💬 18 genes, 30 drugs (DrugBank) and 79 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia
|
Ketamine hydrochloride Ketamine hydrochloride 💬Spinocerebellar ataxia
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬165. Spinocerebellar ataxia
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Spinocerebellar ataxia 💬 18 genes, 30 drugs (DrugBank) and 79 diseases |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia
|
Ketamine Ketamine 💬Spinocerebellar ataxia
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬165. Spinocerebellar ataxia
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Staphylococcus aureus infection 💬 29 genes, 26 drugs (DrugBank) and 42 diseases |
PLG 1件: PLG 💬Staphylococcus aureus infection
|
Tranexamic acid Tranexamic acid 💬Staphylococcus aureus infection
| Tranexamic acid | 046 7件: 46, 65, 70, 215, 227, 274, 299 💬167. Staphylococcus aureus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 90 diseases |
GRIN2A 2件: GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Systemic lupus erythematosus
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬168. Systemic lupus erythematosus
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 90 diseases |
GRIN2A 2件: GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Systemic lupus erythematosus
| Ketamine | 006 6件: 6 , 13, 70, 113, 156, 215 💬168. Systemic lupus erythematosus
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
ADRB3 1件: ADRB3 💬Thermogenesis
|
Propranolol hydrochloride Propranolol hydrochloride 💬Thermogenesis
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬170. Thermogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
ADRB3 1件: ADRB3 💬Thermogenesis
|
Propranolol Propranolol 💬Thermogenesis
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬170. Thermogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬172. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬172. Vascular smooth muscle contraction
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Alcoholism
29 genes, 80 drugs (DrugBank) and 63 diseases
Aldosterone synthesis and secretion
20 genes, 43 drugs (DrugBank) and 63 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Amyotrophic lateral sclerosis
39 genes, 58 drugs (DrugBank) and 116 diseases
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Circadian entrainment
22 genes, 42 drugs (DrugBank) and 62 diseases
Cocaine addiction
15 genes, 67 drugs (DrugBank) and 58 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cortisol synthesis and secretion
15 genes, 39 drugs (DrugBank) and 63 diseases
Cushing syndrome
23 genes, 56 drugs (DrugBank) and 71 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Dilated cardiomyopathy
23 genes, 61 drugs (DrugBank) and 93 diseases
Dopaminergic synapse
33 genes, 105 drugs (DrugBank) and 105 diseases
Drug metabolism - other enzymes
9 genes, 13 drugs (DrugBank) and 58 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Glutamatergic synapse
23 genes, 32 drugs (DrugBank) and 82 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Huntington disease
26 genes, 42 drugs (DrugBank) and 91 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Long-term potentiation
18 genes, 37 drugs (DrugBank) and 87 diseases
Morphine addiction
43 genes, 70 drugs (DrugBank) and 80 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Nicotine addiction
30 genes, 37 drugs (DrugBank) and 48 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Pyrimidine metabolism
5 genes, 9 drugs (DrugBank) and 49 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Renin-angiotensin system
6 genes, 22 drugs (DrugBank) and 33 diseases
Salivary secretion
20 genes, 75 drugs (DrugBank) and 75 diseases
Spinocerebellar ataxia
18 genes, 30 drugs (DrugBank) and 79 diseases
Staphylococcus aureus infection
29 genes, 26 drugs (DrugBank) and 42 diseases
Systemic lupus erythematosus
30 genes, 49 drugs (DrugBank) and 90 diseases
Thermogenesis
17 genes, 31 drugs (DrugBank) and 89 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases